Publicaciones en las que colabora con José Ramón González Juanatey (153)
2024
-
Pseudotransposition of the great leads
PACE - Pacing and Clinical Electrophysiology, Vol. 47, Núm. 2, pp. 233-235
2023
-
Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients
Transplantation, Vol. 107, Núm. 2, pp. 466-474
-
Atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy: a prospective multicentre study
ESC Heart Failure, Vol. 10, Núm. 5, pp. 3055-3066
-
Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation
Cells, Vol. 12, Núm. 4
-
Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials
The American journal of cardiology, Vol. 205, pp. 321-324
-
Clinical and cost-effectiveness results of an on-call program for pacemaker implantations
Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 936-937
-
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593
-
Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients
Transplantation, Vol. 107, Núm. 9, pp. 2064-2072
-
Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase
Primary Care Diabetes, Vol. 17, Núm. 4, pp. 366-372
-
Effect of dapagliflozin on COVID-19 infection and risk of hospitalization
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2335-2342
-
Impact of the COVID-19 pandemic above a universal electronic consultation program (e-consultation) between general practitioners and cardiologists
Revista Clinica Espanola, Vol. 223, Núm. 6, pp. 350-358
-
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis
Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75
-
Plasma miR-486-5p Expression Is Upregulated in Atrial Fibrillation Patients with Broader Low-Voltage Areas
International Journal of Molecular Sciences, Vol. 24, Núm. 20
-
Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation
International Journal of Molecular Sciences, Vol. 24, Núm. 18
-
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats
Biomedicine and Pharmacotherapy, Vol. 161
2022
-
Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry
European Journal of Internal Medicine, Vol. 99, pp. 45-56
-
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
BMC Medicine, Vol. 20, Núm. 1
-
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry
Europace, Vol. 24, Núm. 5, pp. 721-728
-
Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients
Journal of Heart and Lung Transplantation, Vol. 41, Núm. 2, pp. 137-147
-
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry
European Journal of Clinical Investigation, Vol. 52, Núm. 12